In our study, transcriptomic analysis revealed increased NLRP3 gene expression in the hyperreactive clinical form (MCL) compared to control, ADCL, and LCL forms, as well as a higher density of immunostained cells (NLRP3+) in situ when compared with other ACL forms. This evidence concerns the gene NLRP3 and autosomal dominant cutis laxa.